Subscribe for $2

Subscribe for 2 $

B2B Data & Analytics

Acrivon Therapeutics Aktie News & Pressemeldungen

Acrivon Therapeutics Eulerpool News

Acrivon Therapeutics Eulerpool News

Acrivon Therapeutics Stock News

Acrivon Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Acrivon Therapeutics news here.

September 18 ·
SeekingAlpha
Breaking Down Acrivon: Deep Dive Into Revenue, Profitability, And Prospects
September 17 ·
TipRanks
Acrivon Therapeutics: Buy Rating Justified by Promising Clinical Data and Strategic Research Initiatives
September 16 ·
TipRanks
Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer
September 16 ·
TipRanks
TD Cowen Remains a Buy on Acrivon Therapeutics, Inc. (ACRV)
September 16 ·
Thefly.com
Acrivon Therapeutics price target raised by $3 at BMO Capital, here's why
September 16 ·
TipRanks
Acrivon Therapeutics: Promising Trial Results and FDA Clearance
September 16 ·
TipRanks
Piper Sandler Keeps Their Buy Rating on Acrivon Therapeutics, Inc. (ACRV)
September 16 ·
Thefly.com
Acrivon Therapeutics upgraded to Buy on cancer data at Ladenburg
September 16 ·
Thefly.com
Ladenburg gets more bullish on Acrivon Therapeutics, upgrades shares
September 16 ·
TipRanks
Promising Efficacy and Safety Profile of ACR-368 Bolster Buy Rating for Acrivon Therapeutics

1

2

1

2

Acrivon Therapeutics Stock Press Releases

Acrivon Therapeutics regularly publishes news on the company's website that are relevant for investors.

Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2